Amgen Inc. (AMGN)
NASDAQ: AMGN · IEX Real-Time Price · USD
310.77
-0.24 (-0.08%)
At close: Jul 2, 2024, 4:00 PM
310.62
-0.15 (-0.05%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Amgen Revenue
Amgen had revenue of $29.53B in the twelve months ending March 31, 2024, with 12.76% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $7.45B with 21.98% year-over-year growth. In the year 2023, Amgen had annual revenue of $28.19B with 7.09% growth.
Revenue (ttm)
$29.53B
Revenue Growth
+12.76%
P/S Ratio
5.64
Revenue / Employee
$1,106,067
Employees
26,700
Market Cap
166.71B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
Dec 31, 2019 | 23.36B | -385.00M | -1.62% |
Dec 31, 2018 | 23.75B | 898.00M | 3.93% |
Dec 31, 2017 | 22.85B | -142.00M | -0.62% |
Dec 31, 2016 | 22.99B | 1.33B | 6.14% |
Dec 31, 2015 | 21.66B | 1.60B | 7.97% |
Dec 31, 2014 | 20.06B | 1.39B | 7.43% |
Dec 31, 2013 | 18.68B | 1.41B | 8.17% |
Dec 31, 2012 | 17.27B | 1.68B | 10.80% |
Dec 31, 2011 | 15.58B | 529.00M | 3.51% |
Dec 31, 2010 | 15.05B | 411.00M | 2.81% |
Dec 31, 2009 | 14.64B | -361.00M | -2.41% |
Dec 31, 2008 | 15.00B | 232.00M | 1.57% |
Dec 31, 2007 | 14.77B | 503.00M | 3.53% |
Dec 31, 2006 | 14.27B | 1.84B | 14.79% |
Dec 31, 2005 | 12.43B | 1.88B | 17.82% |
Dec 31, 2004 | 10.55B | 2.19B | 26.26% |
Dec 31, 2003 | 8.36B | 2.83B | 51.29% |
Dec 31, 2002 | 5.52B | 1.51B | 37.54% |
Dec 31, 2001 | 4.02B | 386.30M | 10.64% |
Dec 31, 2000 | 3.63B | 289.30M | 8.66% |
Dec 31, 1999 | 3.34B | 621.90M | 22.88% |
Dec 31, 1998 | 2.72B | 317.20M | 13.21% |
Dec 31, 1997 | 2.40B | 161.20M | 7.20% |
Dec 31, 1996 | 2.24B | 299.90M | 15.46% |
Dec 31, 1995 | 1.94B | 292.00M | 17.72% |
Dec 31, 1994 | 1.65B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Elevance Health | 171.75B |
Pfizer | 55.09B |
Sanofi | 51.60B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
Danaher | 22.52B |
AMGN News
- 13 days ago - M&A Is Back. 4 Stocks That Could Be Targets. - Barrons
- 18 days ago - FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE - PRNewsWire
- 20 days ago - AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024 - PRNewsWire
- 27 days ago - AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE - PRNewsWire
- 27 days ago - Amgen's drug meets main goal in late-stage study for rare disease - Reuters
- 27 days ago - AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD) - PRNewsWire
- 4 weeks ago - AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE - PRNewsWire
- 4 weeks ago - Should you buy Amgen's stock above $300? - Invezz